Search research articles
Contact Us
Filters
Showing results (231-240 of 596) with videos related to
Page
of 60
Sort By:
Biomed Research International
|
August 30, 2021
Prevalence of Intestinal Parasite Infections and Their Associated Factors among Food Handlers Working in Selected Catering Establishments from Bule Hora, Ethiopia
Sunil Tulshiram Hajare, Robe Kuti Gobena, Nitin Mahendra Chauhan, et al.
Gastroenterology
|
March 1, 1975
A genetic study of lactose digestion in Nigerian families
O Ransome-Kuti, N Kretchmer, J D Johnson, et al.
Clinical Therapeutics
|
August 19, 2007
Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation
Kathryn J Eagye, Joseph L Kuti, Michael Dowzicky, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 21, 2004
Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts
Srividya Kotapati, David P Nicolau, Charles H Nightingale, et al.
International Journal of Antimicrobial Agents
|
December 19, 2008
Comparative pharmacodynamics for intravenous antibiotics against Gram-negative bacteria in Europe between 2002 and 2006: a report from the OPTAMA program
Pornpan Koomanachai, Jared L Crandon, Joseph L Kuti, et al.
Antimicrobial Agents and Chemotherapy
|
October 8, 2014
In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus
Shawn H MacVane, Wonhee So, David P Nicolau, et al.
Biochimica Et Biophysica Acta
|
July 16, 2016
Brown adipose tissue in obesity: Fractalkine-receptor dependent immune cell recruitment affects metabolic-related gene expression
Ágnes Polyák, Zsuzsanna Winkler, Dániel Kuti, et al.
Journal of Pharmacy Practice
|
November 11, 2017
Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function
Abrar K Thabit, Mordechai Grupper, David P Nicolau, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 28, 2018
Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease
Sandhya Mehta, Sabyasachi Ghosh, Stephen Sander, et al.
Diagnostic Microbiology and Infectious Disease
|
October 12, 2002
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
Joseph L Kuti, Charles H Nightingale, Richard Quintiliani, et al.
Page
of 60
Search research articles
Search
Showing results (231-240 of 596) with videos related to
Sort By:
Page
of 60
Biomed Research International
|
August 30, 2021
Prevalence of Intestinal Parasite Infections and Their Associated Factors among Food Handlers Working in Selected Catering Establishments from Bule Hora, Ethiopia
Sunil Tulshiram Hajare, Robe Kuti Gobena, Nitin Mahendra Chauhan, et al.
Gastroenterology
|
March 1, 1975
A genetic study of lactose digestion in Nigerian families
O Ransome-Kuti, N Kretchmer, J D Johnson, et al.
Clinical Therapeutics
|
August 19, 2007
Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation
Kathryn J Eagye, Joseph L Kuti, Michael Dowzicky, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 21, 2004
Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts
Srividya Kotapati, David P Nicolau, Charles H Nightingale, et al.
International Journal of Antimicrobial Agents
|
December 19, 2008
Comparative pharmacodynamics for intravenous antibiotics against Gram-negative bacteria in Europe between 2002 and 2006: a report from the OPTAMA program
Pornpan Koomanachai, Jared L Crandon, Joseph L Kuti, et al.
Antimicrobial Agents and Chemotherapy
|
October 8, 2014
In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus
Shawn H MacVane, Wonhee So, David P Nicolau, et al.
Biochimica Et Biophysica Acta
|
July 16, 2016
Brown adipose tissue in obesity: Fractalkine-receptor dependent immune cell recruitment affects metabolic-related gene expression
Ágnes Polyák, Zsuzsanna Winkler, Dániel Kuti, et al.
Journal of Pharmacy Practice
|
November 11, 2017
Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function
Abrar K Thabit, Mordechai Grupper, David P Nicolau, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 28, 2018
Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease
Sandhya Mehta, Sabyasachi Ghosh, Stephen Sander, et al.
Diagnostic Microbiology and Infectious Disease
|
October 12, 2002
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
Joseph L Kuti, Charles H Nightingale, Richard Quintiliani, et al.
Page
of 60